Resources

February 9, 2022

Sites NOW: Site-Focused Oncology Trends for 2022

The Sites NOW January discussion, featuring panelists Peter Fredette of IQVIA, Rosemary McQueary of Quality Cancer Care and Alliance, and Alexa Florea from Roche Genentech, highlighted […]
January 20, 2022

Decentralized Clinical Trials: How to Deliver the Complex Efficiently

January 20, 2022

Decentralized Trials & Subcontracting: What Sites Need to Look Out For

Changes brought on by the pandemic have encouraged the industry to adapt quickly, especially when it comes to adoption of new technologies. Many sites pivoted to […]
January 7, 2022

2021 Global Summit Review: Highlights and Takeaways

In November, we reconvened for Sites NOW to discuss the 2021 SCRS Global Site Solutions Summit and some of the highlights from popular sessions. Lindsey Morales […]
January 7, 2022

Tomorrow’s Patient-Centric Trials are Here Today

Ready or not, patient-centric trials fueled by technology and new best practices are here to stay, says David Vulcano, LCSW, MBA, CIP, RAC, vice president for […]
December 20, 2021

2022 Global Oncology Site Solutions Summit Preview

Sandy Smith, Senior Vice President of Clinical Solutions and Strategic Partnering at WCG Clinical and SCRS Global Oncology Summit Chair shares what she is most excited […]
December 6, 2021

Looking Ahead with SCRS Honorary President David Vulcano

Meet SCRS’ new Honorary President, David Vulcano, as we discuss what this new role means to him and SCRS. David shares his vision for the future […]
November 22, 2021

Patient Recruitment Techniques: 2021 SPRIA Recipient Shares Winning Concept

Tune in as Steven Geller, PhD, Medical Director at Centennial Medical Group, shows you the patient recruitment strategy that earned the 2021 SCRS Site Patient Recruitment […]
November 9, 2021

Clinical Research Sites That Embody Patient-Centricity

What does it mean for sites to be patient-centric? Learn from Ellen Price, Director of Patient Engagement at Meridian Clinical Research, the recipient of the 2021 […]